Abstract:OBJECTIVE: To study the correlation between in vitro release and in vivo absorption of captopril delayed-onset, sustained release tablets. METHODS: The in vitro release characteristics of captopril delayed-onset, sustained release tablet were evaluated at 0.1 mol· L-1 hydrochloric acid medium. The results were compared with that of the common delayed tablet. The oral administration absorption in vivo was tested in beagle dogs with a single-dose, crossover study under fasting conditions, comparing the delayed-onset, sustained release tablets (CDSR) and common sustained release tablets (CSR). The fractions absorbed were calculated by the Wagner-Nelson method. The captopril concentration in plasma was determined by a pre-column derivation HPLC with a solid phase extraction. RESULTS: The captopril concentration in plasma was not detected until 2 h after the oral administration, and the peak blood level occurred in 3-5 h after an oral administration, in vitro release started at 3.5 h, the accumulate release percent was about 10% at 5 h, the maximum release was reached in 8-10 h, for the delayed-onset, sustained release tablets. While the captopril concentration was detected at 0.5 h after the oral administration, and the peak blood level occurred in 1-3 h after the oral administration, the accumulate release percent in vitro was about 20% at 1 h, for the common delayed tablets. CONCLUSION: There are some correlation between release in vitro and absorption of the delayed-onset in vivo, sustained release tablets, and the remarkable lag time is observed, compared with the common delayed tablets.

Study on the Rat Intestinal Absorption Kinetics of Duloxetine Hydrochloride in Vitro

Study on Correlation Between in vitro Release and in vivo Absorption of Captopril Delayed-onset, Sustained Release Tablet

Study on Correlation Between {\sl in Vitro} Release and {\sl in Vivo} Absorption of Captopril Delayed--onset, Sustained Release Tablet

Study on the Intestinal Absorption Profiles of Tanshinone IIA and Its Inclusion Complex with Cyclodextrin in Rats.

Study on the Absorption Kinetics of Simvastatin in Rat Small Intestine

PK-PD relationship of poorly absorbable active ingredients from traditional Chinese medicines explaining by metabolic enzyme of gut microbiota: A case study of dehydrocorydaline

Dynamics study on the intestinal absorption of AB0315 in rats

Pharmacokinetics of Duloxetine Hydrochloride Enteric-Coated Tablets in Healthy Volunteers

[Intestinal Absorption of Enteric Coating Potassium Sodium Dehydroandroan Drographolide Succinate Pellets in Rat and in Vivo Pharmacokinetics Study].

In situ Intestinal Absorption Kinetics of Carvedilol Nanosuspensions in Rats

Investigation of the Improved Effects of 2-Hydroxypropyl-β-cyclodextrin on Solubility, Dissolution Rate, and Intestinal Absorptive Profile of Tanshinone IIA in Rats

Study of Experiment of Yanhuning′s Absorption in Small Intestine in Rats

Study on intestinal absorption of clematichinenoside AR in rats by in-situ single-pass perfusion model

Studies on Mechanism to Promote Intestinal Absorption of Cyclosporine A & Formulation Factors

Studies on Rat Intestinal Absorption of Triptolide in Situ

Study on in Situ Intestinal Absorption Kinetics of Icariin in Rats

Study on the Physicochemical Properties and the Intestinal Absorption Kinetics of Norcantharidin in Rats

In Vitro and in Vivo Evaluation of the Effects of Duloxetine on P-gp Function.

Characteristic of intestinal absorption of euphorbia factor L1 by rats single pass intestinal perfusion moder in situ

Studies on Drug Release in Vitro and Absorption in Rat in Vivo of Ginsenoside Rd Solid Lipid Nanoparticles

Intestinal Absorption Kinetics of Rhamnosylvitexin in Rats